欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/5113/001
药品名称Buprenorphin/Naloxon MOLTENI 2 mg/0,5 mg Sublingualtabletten
活性成分
    • BUPRENORPHINE HYDROCHLORIDE 2.16 mg
    • NALOXONE HYDROCHLORIDE dihydrate 0.61 mg
剂型Sublingual tablet
上市许可持有人L. Molteni & C. Dei Fratelli Alitti - Societa di Esercizio - S.p.A. Strada Statale 67, Fraz. Granatieri I-50018 Scandicci (Firence) Italy
参考成员国 - 产品名称Germany (DE)
2199072
互认成员国 - 产品名称
    • Italy (IT)
许可日期2018/04/25
最近更新日期2023/06/15
药物ATC编码
    • N07BC51 buprenorphine, combinations
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase